MagnetisMM-7
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab VS Lenalidomide in Participants with Newly Diagnosed Multiple Myeloma Who Have Had an Autologous Stem Cell Transplant
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 10 by
- Accepting patients
- Accepting patients
- Accepting patients
University of Mississippi Medical Center
Jackson, MS
- Accepting patients
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack Meridian Health
Hackensack, NJ
- Accepting patients
- Accepting patients
- Accepting patients
- Accepting patients
OhioHealth Riverside Methodist Hospital
Columbus, OH
- Accepting patients
Alliance for Multi-Specialty Research
Kansas City, MO
- Accepting patients
Showing 1-10 of 10
1,351 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.